Tralokinumab%20is%20a%20human%20recombinant%20monoclonal%20antibody%20%28mab%29%20of%20the%20subclass%20that%20specifically%20binds%20human%20il-13%2C%20blocking%20interactions%20with%20the%20il-13%20receptor ( DrugBank: Tralokinumab )

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
85特発性間質性肺炎0

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212 
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries